| Bioactivity | G9a-IN-1 (Compound 113) is a G9a protein inhibitor. G9A/EHMT2 is a nuclear histone lysine methyltransferase that catalyzes histone H3 lysine 9 dimethylation (H3K9me2), which is a reversible modification generally associated with transcriptional gene silencing. G9a-IN-1 can be used for the research of autoimmune disorders or cancer[1]. |
| Name | G9a-IN-1 |
| CAS | 1350752-07-6 |
| Formula | C24H36ClN5O2 |
| Molar Mass | 462.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dimitrios Iliopoulos, et al. Small molecules for the treatment of autoimmune diseases and cancer. WO2022031939A1 |
G9a-IN-1
CAS: 1350752-07-6 F: C24H36ClN5O2 W: 462.03
G9a-IN-1 (Compound 113) is a G9a protein inhibitor. G9A/EHMT2 is a nuclear histone lysine methyltransferase that catalyz
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.